91061-77-7 Usage
Uses
Used in Pharmaceutical Research:
CHEMBRDG-BB 6524994 is used as a bioactive compound in pharmaceutical research for its potential medicinal properties. Its unique chemical structure, including the pyrimidine core, chlorophenyl group, and piperidine ring, suggests that it may have applications in the development of new drugs.
Used in Drug Discovery:
In the field of drug discovery, CHEMBRDG-BB 6524994 is utilized as a candidate molecule for further exploration. Its classification as a bioactive small molecule indicates that it could interact with biological targets, potentially leading to the discovery of new therapeutic agents.
Used in Medicinal Chemistry:
CHEMBRDG-BB 6524994 serves as a valuable tool in medicinal chemistry, where it can be studied for its binding affinity to various biological targets. Understanding its interactions can aid in the optimization of its structure for improved potency and selectivity in treating specific diseases.
Used in Chemical Synthesis:
CHEMBRDG-BB 6524994 may also be used in chemical synthesis processes to create derivative molecules with potentially enhanced or modified properties. Such derivatives could then be further investigated for their therapeutic potential.
Note: The specific applications in different industries are not provided in the materials, so the uses listed are general and based on the compound's classification as a bioactive small molecule with potential medicinal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 91061-77-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 91061-77:
(7*9)+(6*1)+(5*0)+(4*6)+(3*1)+(2*7)+(1*7)=117
117 % 10 = 7
So 91061-77-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O4/c1-13-6-8-5-7(10(11)12)3-4-9(8)14-2/h3-5H,6H2,1-2H3,(H,11,12)
91061-77-7Relevant academic research and scientific papers
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
-
Page/Page column 34, (2008/06/13)
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
